Abstract
We describe a case of a 14.5-year-old boy with a clinically aggressive pelvic Ewing sarcoma. The tumor cells showed the presence of a typical t(11;22)(q24;q12) aberration and gains of chromosomes 8, 10, 14, and 21. To determine the size of the trisomy and tetrasomy 8 clones an interphase analysis by fluorescence in situ hybridization with a centromere-specific chromosome 8 probe was performed. Significant quantitative differences between metaphase and interphase data were obtained. It was shown that culturing of bone marrow cells leads to enrichment of tetrasomy 8 population that may be explained by the proliferative advantage of the tetrasomy 8 cells.
| Original language | English |
|---|---|
| Pages (from-to) | 176-178 |
| Number of pages | 3 |
| Journal | Cancer Genetics and Cytogenetics |
| Volume | 90 |
| Issue number | 2 |
| DOIs | |
| State | Published - Sep 1996 |
Funding
| Funders |
|---|
| Israel Cancer Research Fund |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'In vitro proliferative advantage of bone marrow cells with tetrasomy 8 in Ewing sarcoma'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver